IVIg vs placebo
Death · adults with renal vasculitis
Intravenous immunoglobulin showed no clear difference in death compared with placebo (low certainty).
1 finding from 1 review
- RR 0.2 [0.01, 3.88]1 study · 34 participantsLow
Intravenous immunoglobulin showed no clear difference in death compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Intravenous immunoglobulin may leads to higher response at 3 months compared with placebo (low certainty).
Intravenous immunoglobulin showed no clear difference in relapse at 3 months compared with placebo (low certainty).
Intravenous immunoglobulin may leads to higher adverse events compared with placebo (low certainty).
The review found no eligible studies for this question.